Similar articles

• Risk factors for breakthrough infection in children with primary vesicoureteral reflux.

  Shiraishi K, Yoshino K, Watanabe M, Matsuyama H, Tanikaze S. Shiraishi K, et al. J Urol. 2010 Apr;183(4):1527-31. doi: 10.1016/j.juro.2009.12.039. Epub 2010 Feb 20. J Urol. 2010. PMID: 20172558
• Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.

  Cheng CH, Tsai MH, Huang YC, Su LH, Tsau YK, Lin CJ, Chiu CH, Lin TY. Cheng CH, et al. Pediatrics. 2008 Dec;122(6):1212-7. doi: 10.1542/peds.2007-2926. Pediatrics. 2008. PMID: 19047236
• Outcome of antibiotic prophylaxis discontinuation in patients with persistent vesicoureteral reflux initially presenting with febrile urinary tract infection: time to event analysis.

  Leslie B, Moore K, Salle JL, Khoury AE, Cook A, Braga LH, Bägli DJ, Lorenzo AJ. Leslie B, et al. J Urol. 2010 Sep;184(3):1093-8. doi: 10.1016/j.juro.2010.05.013. Epub 2010 Jul 21. J Urol. 2010. PMID: 20650501
• Pediatric urinary tract infection and reflux.

  Ross JH, Kay R. Ross JH, et al. Am Fam Physician. 1999 Mar 15;59(6):1472-8, 1485-6. Am Fam Physician. 1999. PMID: 10193590 Review.
• Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children.

  Peters CA, Skoog SJ, Arant BS Jr, Copp HL, Elder JS, Hudson RG, Khoury AE, Lorenzo AJ, Pohl HG, Shapiro E, Snodgrass WT, Diaz M. Peters CA, et al. J Urol. 2010 Sep;184(3):1134-44. doi: 10.1016/j.juro.2010.05.065. Epub 2010 Jul 21. J Urol. 2010. PMID: 20650499 Review.